The much-proposed 25% general tariff, which US President Donald Trump revealed on August 1, 2025, will exempt Indian drug exports to the US. But the mood is far from festive.
Merck & Co. has initiated a major cost-cutting program that will save $3 billion by 2027. The multiyear program of optimization, outlined in its Q2 2025 earnings announcement
On July 29, Agilent Technologies, a multinational company that specializes in diagnostics and life sciences, opened its new Biopharma Experience Center in Hyderabad. By providing cutting-edge lab equipment, professional training, and assistance
Roche announced today new clinical data on trontinemab, its investigational Alzheimer drug that is intended to target amyloid plaques on an unprecedented scale of precision, to be presented today at the Alzheimer Association International...
Global design and technology services provider Tata Elxsi has partnered strategically with San Francisco-based software 3.0 AI platform KAVIA AI. The company claims that this is designed to manage millions of lines of code and intricate backend
Fujifilm India, the pioneer in healthcare technology, has introduced Endoveda, a smart endoscopy report management application, at the conference ENDOCON 2025 held in Jaipur.
In one of the most significant advancements in medtech, scientists have presented a smart capsule capable of monitoring and treating inflammation of the gut in real-time, which his manageable via smartphone app...
In a remarkable turn of events in the pharmaceutical trade globally, the API China 2025 has concluded its proceedings with a life-colored presence and thriving industry participation. The main event highlighted booming demand of active pharma...
Novo Nordisk is doubling its India operations as it has launched a major expansion at its Global Business Services (GBS) hub in Bengaluru. In July 2025, the company grew its workforce from 2,500 to over 4,500 employees to reflect its strategy...
City doctors have witnessed a 5-7 times increase in acute liver failure cases linked to Hepatitis A. The significant surge in Hepatitis A-linked acute liver failure cases has been registered post the COVID-19
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
